1
|
Terry P, Giovannucci E, Michels KB,
Bergkvist L, Hansen H, Holmberg L and Wolk A: Fruit, vegetables,
dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst.
93:525–533. 2001. View Article : Google Scholar : PubMed/NCBI
|
2
|
Surh YJ: Cancer chemoprevention with
dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Liu RH: Potential synergy of
phytochemicals in cancer prevention: mechanism of action. J Nutr.
134:3479S–3485S. 2004.PubMed/NCBI
|
4
|
Hubscher U, Maga G and Spadari S:
Eukaryotic DNA polymerases. Annu Rev Biochem. 71:133–163. 2002.
View Article : Google Scholar
|
5
|
Bebenek K and Kunkel TA: DNA repair and
replication. Advances in Protein Chemistry. Yang W: 69. Elsevier;
San Diego, CA: pp. 137–165. 2004
|
6
|
Takata K, Shimizu T, Iwai S and Wood RD:
Human DNA polymerase N (POLN) is a low fidelity enzyme capable of
error-free bypass of 5S-thymine glycol. J Biol Chem.
281:23445–23455. 2006. View Article : Google Scholar : PubMed/NCBI
|
7
|
Murakami C, Kumagai T, Hada T, Kanekazu U,
Nakazawa S, Kamisuki S, Maeda N, Xu X, Yoshida H, Sugawara F,
Sakaguchi K and Mizushina Y: Effects of glycolipids from spinach on
mammalian DNA polymerases. Biochem Pharmacol. 65:259–267. 2003.
View Article : Google Scholar : PubMed/NCBI
|
8
|
Ohta K, Mizushina Y, Hirata N, Takemura M,
Sugawara F, Matsukage A, Yoshida S and Sakaguchi K:
Sulfoquinovosyldiacylglycerol, KM043, a new potent inhibitor of
eukaryotic DNA polymerases and HIV-reverse transcriptase type 1
from a marine red alga, Gigartina tenella. Chem Pharm Bull
(Tokyo). 46:684–686. 1998. View Article : Google Scholar : PubMed/NCBI
|
9
|
Hanashima S, Mizushina Y, Ohta K, Yamazaki
T, Sugawara F and Sakaguchi K: Structure-activity relationship of a
novel group of mammalian DNA polymerase inhibitors, synthetic
sulfoquinovosylacylglycerols. Jpn J Cancer Res. 91:1073–1083. 2000.
View Article : Google Scholar
|
10
|
Maeda N, Hada T, Yoshida H and Mizushina
Y: Inhibitory effect on replicative DNA polymerases, human cancer
cell proliferation, and in vivo anti-tumor activity by glycolipids
from spinach. Curr Med Chem. 14:955–967. 2007. View Article : Google Scholar : PubMed/NCBI
|
11
|
Roughan PG and Batt RD: The glycerolipid
composition of leaves. Phytochemistry. 8:363–369. 1969. View Article : Google Scholar
|
12
|
Sugawara T and Miyazawa T: Separation and
determination of glycolipids from edible plant sources by
high-performance liquid chromatography and evaporative
light-scattering detection. Lipids. 34:1231–1237. 1999.PubMed/NCBI
|
13
|
Yunoki K, Sato M, Seki K, Ohkubo T, Tanaka
Y and Ohnishi M: Simultaneous quantification of plant
glyceroglycolipids including sulfoquinovosyldiacylglycerol by
HPLC-ELSD with binary gradient elution. Lipids. 44:77–83. 2009.
View Article : Google Scholar
|
14
|
Kuriyama I, Musumi K, Yonezawa Y, Takemura
M, Maeda N, Iijima H, Hada T, Yoshida H and Mizushina Y: Inhibitory
effects of glycolipids fraction from spinach on mammalian DNA
polymerase activity and human cancer cell proliferation. J Nutr
Biochem. 16:594–601. 2005. View Article : Google Scholar : PubMed/NCBI
|
15
|
Maeda N, Hada T, Murakami-Nakai C,
Kuriyama I, Ichikawa H, Fukumori Y, Hiratsuka J, Yoshida H,
Sakaguchi K and Mizushina Y: Effects of DNA polymerase inhibitory
and antitumor activities of lipase-hydrolyzed glycolipid fractions
from spinach. J Nutr Biochem. 16:121–128. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Matsubara K, Matsumoto H, Mizushina Y,
Mori M, Nakajima N, Fuchigami M, Yoshida H and Hada T: Inhibitory
effect of glycolipids from spinach on in vitro and ex vivo
angiogenesis. Oncol Rep. 14:157–160. 2005.PubMed/NCBI
|
17
|
Maeda N, Matsubara K, Yoshida H and
Mizushina Y: Anti-cancer effect of spinach glycoglycerolipids as
angiogenesis inhibitors based on the selective inhibition of DNA
polymerase activity. Mini Rev Med Chem. 11:32–38. 2011. View Article : Google Scholar : PubMed/NCBI
|
18
|
Bruno A, Rossi C, Marcolongo G, Di Lena A,
Venzo A, Berrie CP and Corda D: Selective in vivo anti-inflammatory
action of the galactolipid monogalactosyldiacylglycerol. Eur J
Pharmacol. 524:159–168. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Mosmann T: Rapid colorimetric assay for
cellular growth and survival: application to proliferation and
cytotoxicity assays. J Immunol Methods. 65:55–63. 1983. View Article : Google Scholar : PubMed/NCBI
|
20
|
Fukuda K, Teramoto Y, Goto M, Sakamoto J,
Mitsuiki S and Hayashida S: Specific inhibition by cyclodextrins of
raw starch digestion by fungal glucoamylase. Biosci Biotechnol
Biochem. 56:556–559. 1992. View Article : Google Scholar : PubMed/NCBI
|
21
|
Sugawara T and Miyazawa T: Digestion of
plant monogalactosyldiacylglycerol and digalactosyldiacylglycerol
in rat alimentary canal. J Nutr Biochem. 11:147–152. 2000.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Matsui Y, Hada T, Maeda N, Sato Y,
Yamaguchi Y, Takeuchi T, Takemura M, Sugawara F, Sakaguchi K,
Yoshida H and Mizushina Y: Structure and activity relationship of
monogalactosyl diacylglycerols, which selectively inhibited in
vitro mammalian replicative DNA polymerase activity and human
cancer cell growth. Cancer Lett. 283:101–107. 2009. View Article : Google Scholar
|
23
|
Grammatikos SI, Subbaiah PV, Victor TA and
Miller WM: n-3 and n-6 fatty acid processing and growth effects in
neoplastic and non-cancerous human mammary epithelial cell lines.
Br J Cancer. 70:219–227. 1994. View Article : Google Scholar : PubMed/NCBI
|
24
|
Coakley M, Banni S, Johnson MC, Mills S,
Devery R, Fitzgerald G, Paul Ross R and Stanton C: Inhibitory
effect of conjugated α-linolenic acid from bifidobacteria of
intestinal origin on SW480 cancer cells. Lipids. 44:249–256.
2009.
|
25
|
Kubben FJ, Peeters-Haesevoets A, Engels
LG, Baeten CG, Schutte B, Arends JW, Stockbrugger RW and Blijham
GH: Proliferating cell nuclear antigen (PCNA): a new marker to
study human colonic cell proliferation. Gut. 35:530–535. 1994.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Bromley M, Rew D, Becciolini A, Balzi M,
Chadwick C, Hewitt D, Li YQ and Potten CS: A comparison of
proliferation markers (BrdUrd, Ki-67, PCNA) determined at each cell
position in the crypts of normal human colonic mucosa. Eur J
Histochem. 40:89–100. 1996.PubMed/NCBI
|
27
|
Maeda N, Kokai Y, Ohtani S, Sahara H,
Kuriyama I, Kamisuki S, Takahashi S, Sakaguchi K, Sugawara F,
Yoshida H, Sato N and Mizushina Y: Anti-tumor effects of
dehydroaltenusin, a specific inhibitor of mammalian DNA polymerase
α. Biochem Biophys Res Commun. 352:390–396. 2007.PubMed/NCBI
|
28
|
Kuriyama I, Mizuno T, Fukudome K,
Kuramochi K, Tsubaki K, Usui T, Imamoto N, Sakaguchi K, Sugawara F,
Yoshida H and Mizushina Y: Effect of dehydroaltenusin-C12
derivative, a selective DNA polymerase α inhibitor, on DNA
replication in cultured cells. Molecules. 13:2948–2961.
2008.PubMed/NCBI
|
29
|
Berdis AJ: DNA polymerases as therapeutic
targets. Biochemistry (Moscow). 47:8253–8260. 2008. View Article : Google Scholar : PubMed/NCBI
|
30
|
Folkman J: Tumor angiogenesis: therapeutic
implications. N Engl J Med. 285:1182–1186. 1971. View Article : Google Scholar : PubMed/NCBI
|
31
|
Folkman J: Tumor angiogenesis. Adv Cancer
Res. 43:175–203. 1985. View Article : Google Scholar
|
32
|
Bossi P, Viale G, Lee AK, Alfano R, Coggi
G and Bosari S: Angiogenesis in colorectal tumors: microvessel
quantitation in adenomas and carcinomas with clinicopathological
correlations. Cancer Res. 55:5049–5053. 1995.PubMed/NCBI
|